SAPROPTERIN DIHYDROCHLORIDE
| Brand name | KUVAN |
|---|---|
| Active ingredient | SAPROPTERIN DIHYDROCHLORIDE |
| Strength | 100MG/PACKET |
| Dosage form | FOR SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9216178*PED | May 2033 | — |
| 9216178 | November 2032 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.